Supplementary Table S1 from Pembrolizumab Monotherapy in Sorafenib-Treated and Treatment-Naïve Advanced Hepatocellular Carcinoma: Long-Term Follow-up of the Open-Label, Phase II KEYNOTE-224 Study

作者：Richard S. Finn, Masatoshi Kudo, Ivan Borbath, Julien Edeline, Stéphane Cattan, Hans Van Vlierberghe, Chris Verslype, D. Palmer, Per Stål, Sadahisa Ogasawara, Arndt Vogel, Stephen L. Chan, Jennifer J. Knox, Bruno Daniele, Amos Odeleye-Ajakaye, Ken Hatogai, Abby B. Siegel, Ann‐Lii Cheng, Jean‐Luc Van Laethem · 年份：2026 · DOI：10.1158/1078-0432.32712424 · 研究领域：Hepatocellular Carcinoma Treatment and Prognosis、Cancer Immunotherapy and Biomarkers、Liver physiology and pathology

<p>Table S1. Representativeness of study participants.</p>